Core B: Biospecimen and Pathology Core

Information

  • Research Project
  • 10247711
  • ApplicationId
    10247711
  • Core Project Number
    P50CA097186
  • Full Project Number
    5P50CA097186-19
  • Serial Number
    097186
  • FOA Number
    PAR-14-353
  • Sub Project Id
    5285
  • Project Start Date
    9/19/2002 - 21 years ago
  • Project End Date
    8/31/2023 - 9 months ago
  • Program Officer Name
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    19
  • Suffix
  • Award Notice Date
    9/1/2021 - 2 years ago

Core B: Biospecimen and Pathology Core

PROJECT SUMMARY/ABSTRACT The Biospecimen and Pathology Core provides part of the infrastructure support for the major projects comprising the Pacific Northwest Prostate Cancer SPORE as well as for research conducted through the developmental research and career enhancement programs. It has been designed to meet the needs of these projects and serve as a resource for collaborative efforts with other SPOREs. This Core will provide a systematic and standardized system of specimen collection, storage, distribution and related clinical/research information dissemination that is based on over two decades of experience. There will be consistency and quality assurance in the pathological analysis of tissue specimens. This Core has 5 components: 1. Clinical specimen acquisition (i.e. tissues, including those from surgery and the rapid autopsy program, serum, plasma and urine), processing, quality control, storage, distribution and database entry; 2. A program to continually improve the quality and efficiency of biospecimen acquisition, processing and storage to increase the fidelity of specimens provided to the SPORE investigators; 3. Maintain prostate cancer xenograft lines established by the Core and make specimens available for biological study and/or perform pre-clinical studies for SPORE investigators and collaborators; 4. Laboratory services, including production of tissue microarrays, interpretation of immunohistology by urologic pathologists, production of specimen derivatives and perform PSA immunoassays for research; 5. An administrative program to obtain samples from minorities, prioritize the distribution of specimens, ensure patient confidentiality and compliance with IRB requirements, maintain and improve quality control measures and interact with other SPOREs. Specimens from our repository, especially those from our rapid autopsy program (e.g. PC bone metastases) and our LuCaP series of prostate cancer xenografts have been, and will continue to be distributed to other PC investigators on an international basis.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    P50
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    270185
  • Indirect Cost Amount
    0
  • Total Cost
  • Sub Project Total Cost
    268278
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NCI:268278\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    FRED HUTCHINSON CANCER RESEARCH CENTER
  • Organization Department
  • Organization DUNS
    078200995
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981094433
  • Organization District
    UNITED STATES